(firstQuint)Female Sex is an Independent Predictor of Death and Bleeding Among Fibrinolytic Treated Patients With AMI.

 The Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes (GUSTO) V trial examined a large, contemporary cohort of women and men with ST elevation myocardial infarction (STEMI) treated with fibrinolytic therapy.

 The objective of the present study was to evaluate sex differences in presentation, management and outcome in GUSTO V.

.

 Female Sex is an Independent Predictor of Death and Bleeding Among Fibrinolytic Treated Patients With AMI@highlight

This study evaluated differences between men and women in the presentation, management and outcome of heart attacks within the GUSTO V study.

